Literature Review

00:00
34:58
Sign in or subscribe to listen

No me gusta!

The flash player was unable to start. If you have a flash blocker then try unblocking the flash content - it should be visible below.

Brian T. -

I just wanted to make sure the community knew that the Colchicine for Acute Pericarditis NEJM paper reviewed on EM:RAP is in-fact a repeat and confirmation of previous findings (mostly). The same group ran essential the same trial, randomized but not blinded in 2005, and had essentially identical findings:
•Decreases symptoms at 72 hrs, 12 vs. 37%
•Decreases recurrence, 11 vs. 32 %
•NNT = 5

http://circ.ahajournals.org/content/112/13/2012.short

brendan c. -

Thank you for finally discussing infected stone! The next obvious question is: what do you do with these people? My current practice, that urology won't always do @ first suggestion, is fever, pyelo, anything "sick" goes to OR. The remainder (who urology says to d/c) go to observation. There are always exceptions, but this seems the safest approach. Mostly based on nothing except personal experience. BTW we run our own OBS unit.
Thoughts?

Jerry J., M.D. -

I tried to look up the c-spine article discussed on the "Literature Review" topic #1. The article reportedly from "The Journal of Trauma" Sept 2012 with a title of : "Clinic Clearance of the c-spin in a patient with distracting injury. Is it time to dispel the myth?"
There is a discussion between our surgeons and myself about c-spine clearance. I went to the website to find the article and page number to give the surgeon. I searched old editions, Sept 2012 and found no such article! Was their a misquote in the date? The journal?
Your help would be appreciated.

Mel H. -

Here is the reference from PubMed:

J Trauma Acute Care Surg. 2012 Aug;73(2):498-502. Clinical clearance of the cervical spine in patients with distracting injuries: It is time to dispel the myth. Rose MK1, Rosal LM, Gonzalez RP, Rostas JW, Baker JA, Simmons JD, Frotan MA, Brevard SB.

To join the conversation, you need to subscribe.

Sign up today for full access to all episodes and to join the conversation.